Jpmorgan Chase & CO Medicinova Inc Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in Medicinova Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 8,676 shares of MNOV stock, worth $10,845. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,676
Previous 1,276
579.94%
Holding current value
$10,845
Previous $2,000
500.0%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding MNOV
# of Institutions
22Shares Held
5.08MCall Options Held
0Put Options Held
0-
Essex Woodlands Management, Inc. The Woodlands, TX1.11MShares$1.38 Million0.52% of portfolio
-
Black Rock Inc. New York, NY695KShares$868,6780.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA687KShares$858,2210.0% of portfolio
-
Citigroup Inc592KShares$739,9460.0% of portfolio
-
Geode Capital Management, LLC Boston, MA526KShares$657,3650.0% of portfolio
About MEDICINOVA INC
- Ticker MNOV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,046,200
- Market Cap $61.3M
- Description
- MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and ...